Примери за използване на Delayed hypersensitivity на Английски и техните преводи на Български
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Delayed hypersensitivity.
Immediate and delayed hypersensitivity.
Delayed hypersensitivity allergy, or cusdehaaa.
Allergens on the skin usually cause delayed hypersensitivity reactions.
Immediate or delayed hypersensitivity reactions such swelling of lips, tongue and throat(angioedema).
The risk of acute infusion related reactions and delayed hypersensitivity reactions.
In clinical studies, delayed hypersensitivity reactions have been reported.
On the second andsubsequent exposures to PPD, an allergic reaction can develop within 6 to 72 hours(delayed hypersensitivity).
Uncommon: immediate or delayed hypersensitivity reaction(urticaria, rash, itching, dermatitis, angioedema).
The risk of acute hypersensitivity reactions(including anaphylactic shock) and delayed hypersensitivity reactions.
In the psoriasis studies, delayed hypersensitivity reactions occurred early in the treatment course.
If patients are re-treated after a prolonged period,they must be closely monitored for signs and symptoms of delayed hypersensitivity.
Purchase or conduct analysis tests such as for example delayed hypersensitivity checks, or intradermal and pricks, plot.
Immediate and delayed hypersensitivity reactions, e.g. exanthema, urticaria, pruritus, dermatitis, angioedema and anaphylactic reaction.
Available data suggest an increased risk for delayed hypersensitivity with increasing Remicade-free interval.
Delayed hypersensitivity reactions- Allergic reactions mediated by T cells that occur hours to days after exposure.
Infliximab has been associated with systemic injection reactions,anaphylactic shock and delayed hypersensitivity reactions(see section 4.8).
Abscesses, granuloma and immediate or delayed hypersensitivity after hyaluronic acid and/or lidocaine injections have also been reported.
Infliximab has been associated with acute infusion-related reactions,including anaphylactic shock, and delayed hypersensitivity reactions(see section 4.8).
In clinical studies delayed hypersensitivity reactions have been uncommon and have occurred after Remicade-free intervals of less than 1 year.
Some patients can experience anaphylactic shock(a severe allergic reaction) during infusion, or delayed hypersensitivity(allergic reaction after the first exposure to the medicine).
In clinical studies delayed hypersensitivity reactions have been uncommon and have occurred after Remicade-free intervals of less than 1 year.
Infusion reactions and hypersensitivity Infliximab has been associated with acute infusion-related reactions,including anaphylactic shock, and delayed hypersensitivity reactions(see section 4.8).
To detect the delayed hypersensitivity reaction, latex, its preservatives and accelerators are placed on the skin using a standard patch test.
This is indicative that serious cutaneous reactions with tetrazepam are probably linked to a type IV delayed hypersensitivity mechanism, as supported by positive patch tests in 79 out of 115 cases having had an allergy test.
In clinical studies, delayed hypersensitivity reactions have been uncommon and have occurred after Remicade-free intervals of less than 1 year(see sections 4.4 and 4.8).
This is because of the intrinsic ability of proteins and other biological medicines to cause an unwanted immune response, which,in rare cases, could cause a serious adverse reaction(e.g. anaphylaxis or delayed hypersensitivity) or reduced efficacy.
On the part of immunity- the reaction of delayed hypersensitivity develops infrequently(with each subsequent application of the drug, the reaction from the immune system develops more pronounced).
When considering data in support of the safety issues, the PRAC was of the view that ambroxol- andbromhexine-containing products are associated with case reports of immediate and delayed hypersensitivity including hypersensitivity reactions, anaphylactic reactions including anaphylactic shock, angioedema, pruritus, rash and urticaria.
In clinical studies, delayed hypersensitivity reactions have been uncommon and have occurred after infliximab-free intervals of less than 1 year(see sections 4.4 and 4.8). The safety and efficacy of re- administration after an infliximab-free interval of more than 16 weeks has not been established.